PYNC2426 Last Name ____________________________________________ First Name _ ___________________________________ MI _ _____ Evaluation (Continued) (Completion of this form is mandatory) Elite Learning
C heck the letter grade which best represents each of the following statements .
S trongly
S trongly D isagree
A gree
A gree
N eutral
D isagree
Learning Objectives (After completing this course, I am able to):
Ethics in Behavioral Health Documentation: Reasons, Risks, and Rewards - 3 Hours (Course expires 7/10/2027) Explain the rationale for high-quality documentation. A B C D F Describe the content of good clinical documentation. A B C D F Identify aspects of clinical documentation that present potential ethical problems. A B C D F Describe decision making in ethical documentation. A B C D F Discuss proper documentation within integrated care settings. A B C D F Recognize documentation risks specific to digital record-keeping. A B C D F
Anxiety Disorders - 15 Hours (Course expires 4/30/2028) Review basic concepts related to anxiety disorders, including safety behaviors/signals and primaryfeatures.
A
B
C
D
F
Outline the epidemiology of anxiety disorders in the United States. Describe general risk factors for and comorbidities of anxiety disorders.
A
B
C
D
F
A
B
C
D
F
Describe risk factors for and the clinical course of specific anxiety disorders.
A
B
C
D
F
Discuss the pathogenesis of anxiety disorders in relation to contributing genetic, physiologic, and psychologic factors. Review the pathophysiology of specific anxiety disorders, including social anxiety disorder,agoraphobia, and specific phobia. Apply the clinical and diagnostic criteria for anxiety disorders presented in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Analyze key components of screening and select appropriate screening tools for identification of anxiety disorders.
A
B
C
D
F
A
B
C
D
F
A
B
C
D
F
A
B
C
D
F
Conduct an informed clinical evaluation and select laboratory testing, in consideration of the differential diagnosis of anxiety disorders. A
B
C
D
F
Describe general treatment considerations for anxiety disorders, including predictors of response or nonresponse to therapy. Discuss the role and efficacy of psychotherapy approaches in the treatment of anxiety disorders. Select a pharmacotherapy option appropriate to a given patient’s specific diagnosis, age, and comorbidities. Devise a strategy for management and follow-up designed to improve outcomes. Provide patient education more effectively, in relation to specific anxiety disorders. Address the efficacy, safety and limitations of novel, emerging, and alternative/ complementary approaches to the treatment of anxiety disorders.
A
B
C
D
F
A
B
C
D
F
A
B
C
D
F
A A
B B
C C
D D
F F
A
B
C
D
F
Signature _________________________________________________________________________________ Signature required to receive continuing education credit.
148
EliteLearning.com/Psychology
Powered by FlippingBook